课题基金 / 基金详情

Diabetic nephropathy and apolipoprotein E2 allele

Diabetic nephropathy and apolipoprotein E2 allele
糖尿病肾病与载脂蛋白E2等位基因
批准号:
12671128
负责人:
ETO Masaaki
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ETO Masaaki的其他基金

相似基金

相关文献

中文摘要
翻译
以前我们证明载脂蛋白(apo)E e2等位基因与糖尿病肾病的进展有关。本研究旨在进一步探讨载脂蛋白E基因多态性和血浆残余脂蛋白与糖尿病肾病的关系。将158例糖尿病病程10年以上的2型糖尿病患者分为3组,分别为apo E组、apo E组、apo E组和apo E组。载脂蛋白E2,E3/3和E4.测定血浆脂质和残余脂蛋白水平,探讨富含载脂蛋白E2的甘油三酯(TG)脂蛋白(包括残余脂蛋白)对人肾小球系膜细胞(HMCs)胆固醇酯蓄积的影响。通过测量14 C-油酸酯掺入胆固醇酯的刺激来估计。载脂蛋白E2型糖尿病患者的显性肾病发生率(59.1%)明显高于载脂蛋白E3/3型(34.3%)和载脂蛋白E4型糖尿病患者(8.8%);载脂蛋白E4型糖尿病患者的正常白蛋白尿发生率(67.6%)明显高于载脂蛋白E3/3型(34.3%)和载脂蛋白E2型(4.5%)。对数回归分析显示,载脂蛋白E2和载脂蛋白E4基因型与显性肾病的比值比分别为10.179(p= 0.00349)和0.129(p=0.0028)。与apo E3/3患者相比,apo E2患者的血浆甘油三酯和残粒样脂蛋白颗粒(RLP)-chol水平显著较高,apo E4患者的血浆甘油三酯和残粒样脂蛋白颗粒(RLP)-chol水平显著较低。载脂蛋白E2富TG的脂蛋白比载脂蛋白E3/3或载脂蛋白E4富TG的脂蛋白更能促进HMCs胆固醇酯的积累。载脂蛋白E2是糖尿病肾病的阳性遗传因子,载脂蛋白E4是糖尿病肾病的阴性遗传因子。载脂蛋白E2 TG丰富的脂蛋白被HMCs更贪婪地摄取。残余脂蛋白可能在糖尿病肾病的进展中起重要作用。
英文摘要
Previously we demonstrated that the apolipoprotein (apo) E e2 allele is associated with the progression of diabetic nephropathy. The aim of the present study is to further investigate the association between apo E genetic polymorphism, plasma remnant lipoproteins and diabetic nephropathy. One hundred and fifty eight type 2 diabetic patients who had a diabetes duration over 10 years were divided into the 3 apo E groups ; apo E2, E3/3 and E4.Plasma levels of lipids and remnant lipoproteins were measured.The effect of apo E2 triglyceride (TG)-rich lipoproteins including remnant lipoproteins on accumulation of cholesteryl esters by human mesangial cells (HMCs) was estimated by measurement of the stimulation of 14C-oleate incorporation into cholesteryl esters. The frequency of overt nephropathy was significant^ higher in apo E2 diabetic patients (59.1%) than in apo E3/3 (34.3%) or apo E4 patients (8 8%) and the frequency of normoalbuminuria was significantly higher in apo E4 diabetic patients (67 6%) than in apo E3/3 (34.3%) or apo E2 patients (4.5%). Logistical regression analysis showed that odds ratios of apo E2 and apo E4 genotypes for the presence of overt nephropathy were 10.179 (p=00349) and 0.129 (p=0.0028), respectively. Plasma levels of triglyceride and remnant-like lipoprotein particles (RLP)-chol and were significantly higher in apo E2 patients, and significantly lower, n apo E4 patients than in apo E3/3 patients. Apo E2 TG-rich lipoproteins stimulated accumulate of cholesteryl esters by HMCs significantly more than apo E3/3 or apo E4 TG-rich lipoproteins. Apo E2, s a positive genetic factor and apo E4 is a negative genetic factor for diabetic nephropathy. Apo E2 TG-rich lipoproteins were uptaken more avidly by HMCs. Remnant lipoproteins may have an important role in the progression of diabetic nephropathy.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Eto M, Saito M, Kaku K, et al.: "Apolipoprotein E genetic polymorphism, remanat lipoproteins and nephropathy in type 2 diabetic patients."American J Kidney Diseases. (2002)
Eto M、Saito M、Kaku K 等人:“载脂蛋白 E 遗传多态性、残余脂蛋白和 2 型糖尿病患者的肾病。”美国肾脏病杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwashima Y,Eto M,Hata A,Kaku K,Horiuchi S,Ushibuki F,Sano H,: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Comm.. 277. 368-380 (2000)
Iwashima Y、Eto M、Hata A、Kaku K、Horiuchi S、Ushibuki F、Sano H,:“培养的人单核细胞来源的巨噬细胞中高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem.Biophys.Res.Comm
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SaitoM, EtoM, KakuK.: "Remant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apolipoprotein E2 genotypes"Metabolism. (2002)
SaitoM、EtoM、KakuK.:“具有载脂蛋白 E3/3 基因型和载脂蛋白 E2 基因型的 2 型糖尿病患者中的残余样脂蛋白颗粒 (RLP)”代谢。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
IwashimaY, Eto M, HataA, Kaku K, Horiuchi S, Ushibuki F, SanoH: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem. Biophys. Res. Comm.. 277. 368-380 (2000)
IwashimaY、Eto M、HataA、Kaku K、Horiuchi S、Ushibuki F、SanoH:“在培养的人单核细胞来源的巨噬细胞中,高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug intervention
    • 批准号:
      19590155
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2007
    • 负责人:
      ETO Masaaki
    • 依托单位:
    Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathy
    • 批准号:
      14571112
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2002
    • 负责人:
      ETO Masaaki
    • 依托单位:
    Study on the significance of apo E in aherosclerosis
    • 批准号:
      05670407
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      ETO Masaaki
    • 依托单位:
    海外基金